Did you know?

Neumora Therapeutics (NASDAQ: NMRA), a biotech company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, went public on September 15th with ...Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...markets.businessinsider.com - November 27 at 10:19 AM. Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study. finance.yahoo.com - November 27 at 10:19 AM. Neumora Therapeutics (NASDAQ:NMRA) Shares Gap Up to $11.69. americanbankingnews.com - November 24 at 5:19 AM.Neumora Therapeutics, Inc. (NASDAQ: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the pricing of its initial public offering of ...Obtenha uma breve visão geral das finanças de NEUMORA THERAPEUTICS INC com todos os números importantes. Veja o último NMRA demonstração de resultados, …The latest price target for . Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on November 8, 2023.The analyst firm set a price target for $20.00 expecting NMRA to rise to within 12 ... Posted by Defense World Staff on Nov 24th, 2023. Shares of Neumora Therapeutics, Inc. ( NASDAQ:NMRA – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed ...Victor J. Blue/Bloomberg. Shares of Watertown biotech Neumora Therapeutics retreated 4.4 percent Friday, in the company’s debut on the Nasdaq stock exchange, after it raised $250 million in an ...Find the latest historical data for Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com.Neumora Therapeutics (NASDAQ: NMRA), a biotech company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, went public on September 15th with ...15 Sep 2023 ... ... Nasdaq under the NMRA ticker, which could give it a market valuation of $2.74 billion if fully exercised. It is also due to make its debut ...NMRA-266 is an investigational positive allosteric modulator of the M4 muscarinic receptor subtype, a clinically validated target for the treatment of schizophrenia. Neumora exclusively licensed ...Neumora Therapeutics, Inc.(NasdaqGS:NMRA) added to NASDAQ Composite Index Sep. 18: CI Neumora Therapeutics, Inc. has completed an IPO in the amount of $250.07 million. ... (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist in Phase 3 development as a potential monotherapy treatment for …The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on Wednesday, November 8, 2023. The analyst firm set a price target ...Stock Quote. NASDAQ GS: NMRA. $12.33. Dec 1, 2023 4:00 PM EST. Change. +0.08 (+0.65%). Volume. 232,481. Today's Open. $12.24. Previous Close. $12.25. Today's ...1.55. EBIT. -130.9. -237.31. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Neumora Therapeutics, Inc. (NMRA). See many years of revenue, expenses and ...Insiders and Institutions Are Buying These Robot Stocks. This page (NASDAQ:NMRA) was last updated on 11/24/2023 by MarketBeat.com Staff. Adding. Choose a ...Created with Sketch. when trading, helping you to optimize youShares of Neumora Therapeutics Inc (NASDAQ: NMRA) were t Which Neumora Therapeutics insiders have been buying company stock? The following insiders have purchased NMRA shares in the last 24 months: Amgen Inc ($29,999,985.00), Arch Venture Partners Xii, Llc ($2,626,582.57), Henry O Gosebruch ($189,300.00), and Kristina Burow ($28,803,319.17). /EIN News/ -- WATERTOWN, Mass., Nov. 01, 2023 (GLOBE Nov 27, 2023 · The latest price target for Structure Therapeutics ( NASDAQ: GPCR) was reported by JMP Securities on Monday, November 20, 2023. The analyst firm set a price target for 91.00 expecting GPCR to rise ... VinFast Auto Ltd. (NASDAQ:VFS) gained 13.6% to $12.73 f

EHang Holdings Ltd ADR (NASDAQ:EH) showed a performance of -24.51% in past 30-days. Number of shares sold short was 8.79 million shares which calculate 11.8 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $222.79 to the stock, which implies a rise of 93.55% to its current value.NASDAQ:NMRA Neumora Therapeutics (NMRA) Stock Price, News & Analysis $11.91 +0.22 (+1.88%) (As of 11/22/2023 ET) Compare Today's Range $11.76 $12.14 50-Day Range $9.64 $16.25 52-Week Range $9.35 $17.74 Volume 137,979 shs Average Volume 342,316 shs Market Capitalization $1.82 billion P/E Ratio N/A Dividend Yield N/A Price Target $22.67Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence.Neumora Therapeutics Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

A. The latest price target for Tilray Brands ( NASDAQ: TLRY) was reported by Roth MKM on Friday, September 1, 2023. The analyst firm set a price target for 2.50 expecting TLRY to rise to within 12 ...Current. -$0.75. 1 Month Ago. -$0.75. 3 Months Ago. N/A. Neumora Therapeutics Inc. analyst estimates, including NMRA earnings per share estimates and analyst recommendations.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Neumora Therapeutics Inc. Common Stock stock price (N. Possible cause: Founded Date 2019. Founders Carol Suh, Mike Poole, Paul L Berns. Operating Status Active. .